FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Clinical trial NCT06636682 · RECRUITING

Trial details

NCT number: NCT06636682
Sponsor: Cellvax Therapeutics Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer (Adenocarcinoma)Prostate CA Prostate Cancers Prostate Cancer (Post Prostatectomy)Prostate Cancer Prostate Cancer Patients Undergoing Radical Prostatectomy High-risk Prostate Cancer

Start date: 2024-10-14
Primary completion: 2027-02-02
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.